The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|13|1|53-67

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.13, Iss.1, 2016-01, pp. : 53-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 14, Iss. 12, 2017-10 ,pp. : 1305-1317

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s disease and NGF signaling

By Salehi A.   Delcroix J.-D.   Swaab D. F.  

Journal of Neural Transmission, Vol. 111, Iss. 3, 2004-03 ,pp. : 323-345

Springer Publishing Company

Access to resources Recommend Favorite

Down’’s syndrome and Alzheimer’’s disease: two sides of the same coin

By Potter Huntington  

Future Neurology, Vol. 3, Iss. 1, 2008-01 ,pp. : 29-37

Future Medicine

Access to resources Recommend Favorite

The Failure in NGF Maturation and its Increased Degradation as the Probable Cause for the Vulnerability of Cholinergic Neurons in Alzheimer’s Disease

By Cuello A.   Bruno Martin  

Neurochemical Research, Vol. 32, Iss. 6, 2007-06 ,pp. : 1041-1045

Springer Publishing Company

Access to resources Recommend Favorite

On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease

By Capsoni Simona   Cattaneo Antonino  

Cellular and Molecular Neurobiology, Vol. 26, Iss. 4-6, 2006-07 ,pp. : 617-631

Springer Publishing Company

Access to resources Recommend Favorite